Today has seen the publication of a position statement of medical treatment for transgender adults in the Medical Journal of Australia (equivalent of BMJ, but much lower impact). In this news article, and in the paper itself (both linked below) one of the authors describes how they obtain prescriptions for testosterone.
For background, the Pharmaceutical Benefits Scheme (PBS) is how prescriptions are funded in Australia. The government decides which drugs it will fund, how much, and places criteria on the drug that have to be met in order for them to be happy to subsidise the drug for the patient. These criteria range from minimal to very strict. For testosterone injections these restrictions are “Authority”, one of the strictest. That means a doctor has to call a certain number, give the patient details, tell the person on the phone their patient meets the criteria, and they get given a special code in exchange that goes on that patient’s prescription. Drugs can be prescribed privately if the patient doesn’t meet criteria, but at full cost to the patient.
In this article and in the position statement, the author says, regarding testosterone for transmen:
“It’s not specifically listed [for transgender hormonal management] because the drug companies haven’t done studies specifically in transgender people and haven’t specifically applied to the Pharmaceutical Benefits Advisory Committee to get it transgender-listed,” said Dr Cheung.
“However, transgender men are males, and they have low testosterone levels, so they have androgen deficiency, and they don’t have testicles. So, we’ve been able to use the indication of ‘androgen deficiency due to an established testicular disorder’.
“So, prescribing for transgender males is not a simple thing of just getting a testosterone script. There are a few loops and hurdles that we have to jump over.” (my bold)
So to summarise, they are telling the government that the female they are doing the prescription for is actually male, and they are eligible for the Authority prescription because they have “an established testicular disorder”.
So there you have it. Doctors in Australia - people who I assume did go to medical school - think that females are male, and they’ve convinced themselves so much they’re willing to seemingly defraud the government out of pharmaceutical funding as a result. Females can now have a “testicular disorder” 
.
News article here:
insightplus.mja.com.au/2019/30/empowering-gps-to-care-for-transgender-patients/?utm_source=InSight%2B&utm_campaign=d4b15603c9-EMAIL_CAMPAIGN_2019_08_02_05_15&utm_medium=email&utm_term=0_7346f35e23-d4b15603c9-42141753
Position Statement here:
www.mja.com.au/journal/2019/211/3/position-statement-hormonal-management-adult-transgender-and-gender-diverse
The most unsurprising thing about the consensus? Sexual function is only mentioned ONCE, in the context of some transwomen may want to keep their erections. Nothing at all about the impact on females. Various side effects are listed, but I read it as being very breezy with little warning, more as inconveniences.
I think this is ongoing minimisation of the impacts of these medical decisions, and I find it startling that they have basically admitted they’re lying to the government. That they don’t see it as a lie probably makes it worse.